6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
3m ago	Nayax to Report 2026 Q1 Earnings on May 12, 2026
30m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

About

Immix Biopharma Inc (NASDAQ:IMMX) — investor relations, events, news, and company updates on 6ix.

Latest News

Immix Biopharma to Participate in the Jefferies Global Healthcare Conference

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Immix Biopharma to Participate in Upcoming Investor Conferences

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Financials

Revenue

$0

Market Cap

$473.5 M

EPS

-0.89

Community Chat

Ask AI